Smith, Salley & Associates Thermo Fisher Scientific Inc. Transaction History

Smith, Salley & Associates

  • $1.48 Billion
  • Q3 2024

A detailed history of Smith, Salley & Associates transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 42,717 shares of TMO stock, worth $21.9 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
42,717
Previous 41,583 2.73%
Holding current value
$21.9 Million
Previous $23 Million 14.9%
% of portfolio
1.79%
Previous 1.7%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$531.86 - $624.21 $603,129 - $707,854
1,134 Added 2.73%
42,717 $26.4 Million
Q2 2024

Jul 29, 2024
BUY
$541.52 - $599.02 $1.21 Million - $1.34 Million
2,240 Added 5.69%
41,583 $23 Million
Q1 2024

May 02, 2024
SELL
$528.82 - $599.43 $6.08 Million - $6.89 Million
-11,494 Reduced 22.61%
39,343 $22.9 Million
Q4 2023

Jan 24, 2024
BUY
$431.41 - $532.94 $765,321 - $945,435
1,774 Added 3.62%
50,837 $27 Million
Q3 2023

Oct 27, 2023
BUY
$498.29 - $574.41 $640,302 - $738,116
1,285 Added 2.69%
49,063 $24.8 Million
Q2 2023

Aug 04, 2023
BUY
$508.46 - $591.13 $334,566 - $388,963
658 Added 1.4%
47,778 $24.9 Million
Q1 2023

May 03, 2023
BUY
$535.0 - $604.82 $634,510 - $717,316
1,186 Added 2.58%
47,120 $27.2 Million
Q4 2022

Feb 03, 2023
BUY
$484.71 - $571.37 $104,697 - $123,415
216 Added 0.47%
45,934 $25.3 Million
Q3 2022

Nov 01, 2022
BUY
$507.19 - $604.49 $185,631 - $221,243
366 Added 0.81%
45,718 $23.2 Million
Q2 2022

Aug 01, 2022
BUY
$500.9 - $612.21 $863,551 - $1.06 Million
1,724 Added 3.95%
45,352 $24.6 Million
Q1 2022

May 10, 2022
BUY
$524.0 - $644.92 $291,344 - $358,575
556 Added 1.29%
43,628 $25.8 Million
Q4 2021

Feb 10, 2022
BUY
$569.0 - $667.24 $202,564 - $237,537
356 Added 0.83%
43,072 $28.7 Million
Q3 2021

Nov 05, 2021
BUY
$509.53 - $609.78 $296,036 - $354,282
581 Added 1.38%
42,716 $24.4 Million
Q2 2021

Aug 09, 2021
BUY
$441.0 - $508.24 $510,678 - $588,541
1,158 Added 2.83%
42,135 $21.3 Million
Q1 2021

Apr 30, 2021
BUY
$439.85 - $518.83 $403,782 - $476,285
918 Added 2.29%
40,977 $18.7 Million
Q4 2020

Jan 28, 2021
BUY
$435.06 - $527.66 $658,680 - $798,877
1,514 Added 3.93%
40,059 $18.7 Million
Q3 2020

Nov 05, 2020
BUY
$359.77 - $441.52 $90,662 - $111,263
252 Added 0.66%
38,545 $17 Million
Q2 2020

Aug 04, 2020
BUY
$275.2 - $362.34 $450,227 - $592,788
1,636 Added 4.46%
38,293 $13.9 Million
Q1 2020

Apr 24, 2020
BUY
$255.3 - $340.05 $260,661 - $347,191
1,021 Added 2.87%
36,657 $10.4 Million
Q4 2019

Jan 27, 2020
SELL
$271.93 - $328.04 $152,008 - $183,374
-559 Reduced 1.54%
35,636 $11.6 Million
Q3 2019

Oct 30, 2019
BUY
$268.46 - $305.43 $293,695 - $334,140
1,094 Added 3.12%
36,195 $10.5 Million
Q2 2019

Jul 12, 2019
BUY
$257.51 - $295.55 $356,651 - $409,336
1,385 Added 4.11%
35,101 $10.3 Million
Q1 2019

May 03, 2019
BUY
$212.17 - $273.72 $277,730 - $358,299
1,309 Added 4.04%
33,716 $9.23 Million
Q4 2018

Feb 05, 2019
BUY
$208.47 - $251.98 $200,756 - $242,656
963 Added 3.06%
32,407 $7.25 Million
Q3 2018

Nov 06, 2018
BUY
$205.57 - $244.32 $208,859 - $248,229
1,016 Added 3.34%
31,444 $7.67 Million
Q2 2018

Aug 10, 2018
BUY
$203.14 - $219.53 $173,887 - $187,917
856 Added 2.89%
30,428 $6.3 Million
Q1 2018

May 09, 2018
BUY
$192.98 - $224.11 $66,578 - $77,317
345 Added 1.18%
29,572 $6.11 Million
Q4 2017

Feb 12, 2018
BUY
$182.03 - $200.37 $134,156 - $147,672
737 Added 2.59%
29,227 $5.55 Million
Q3 2017

Nov 02, 2017
BUY
$171.74 - $194.04 $4.89 Million - $5.53 Million
28,490
28,490 $5.39 Million

Others Institutions Holding TMO

# of Institutions
2,829
Shares Held
334M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email